The global veterinary wound care market was valued at US$ 1.1 Billion in 2022 and is expected to reach US$ 2.8 Billion by 2033. The surgical wound care products segment with a market share of more than 61.0% has topped the global market within the product category in 2022 and is expected to grow at a CAGR of close to 8.5% over the forecast period (2023 to 2033).
Market Outlook:
Data Points | Market Insights |
---|---|
Market Value 2022 | US$ 1.1 Billion |
Market Value 2023 | US$ 1.2 Billion |
Market Value 2033 | US$ 2.8 Billion |
CAGR 2023 to 2033 | 8.7% |
Market Share of Top 5 Countries | 49.8% |
Key Market Players | Elanco, Virbac, Medtronic, B Braun, Jorgen Kruuse, Dechra Pharmaceuticals, Neogen Corporation, Ethicon, Sonoma Pharma, Jazz Medical, KAKEN PHARMACEUTICAL CO., LTD. and KOB GmbH |
The need for adequate wound care for animals has become more apparent to pet owners and veterinarians. The increase in awareness campaigns, educational programs, and improved access to information has aided in disseminating awareness about the benefits of timely and adequate wound management for animals, resulting in increased demand for veterinary wound care products.
There is a rising emphasis on providing excellent care to animals in order to promote animal well-being. Wound care or infection treatment in animals is quite critical for reducing pain, avoiding infection, and promoting a faster healing process. Hence, wound management is becoming a higher priority for animal welfare organizations, veterinary practitioners, and pet owners as part of holistic animal healthcare.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for veterinary wound care was around 5.6% of the overall US$ 20.2 Billion of the global wound care market in 2022.
The market for animal wound care is primarily driven by the rise in government and animal welfare association activities, as well as the increased spending on pet adoption and veterinary treatment. New companion animal goods are also being developed by firms, which is expected to expand the industry.
Due to the high occurrence of illnesses that cause wounds in animals, the need for effective and quick wound treatment solutions is anticipated to increase throughout the forecast period.
The increasing number of pet owners and their willingness to spend money on their pets' healthcare has increased the demand for improved wound care solutions in veterinary medicine.
Pet owners are looking for high-quality wound care solutions to encourage healing and improvement in their pets' general well-being. The increased number of animals in need of wound treatment has resulted from increased pet adoption as well as increased rescue efforts of the animals. Wound management is frequently required for these animals due to an increase in the number of injuries, operations, or trauma.
Owed to the above factors, the global market is projected to grow at a CAGR of 8.7% in the forecasted period.
Advancements in veterinary medicine and wound care techniques are expanding the range of treatment options available. New and improved wound care products are being developed to cater to the specific needs of different animal species. Advancements in veterinary medicine have significantly transformed the way animals are cared for, diagnosed, and treated. Over the years, veterinary medicine has evolved through various technological, scientific, and medical breakthroughs, leading to improved animal health, longer lifespans, and enhanced treatment options. This has a positive impact on the adoption of veterinary wound care products and hence presents lucrative opportunities for the key players in the market.
Apart from this, the expansion of veterinary hospitals and clinics, along with the availability of specialized wound care services, presents opportunities for wound care product manufacturers to partner with these facilities and provide their products.
Wound care in veterinary medicine entails dealing with a wide variety of animal types and sizes. Variability in anatomy, physiology, and wound characteristics can make designing and implementing standardized wound care protocols and products across different animals difficult, limiting the availability of universal remedies.
In some areas, access to veterinary facilities with advanced wound care capabilities may be limited. This can be a limitation, especially in rural or underdeveloped areas where veterinary services and specialized wound care knowledge may be limited.
Complying with regulatory regulations and securing required licenses for veterinary wound care products can be difficult and time-consuming. The regulatory framework for veterinary products may vary from country to country, increasing complexity and potential impediments for producers bringing innovative wound care solutions to market.
The USA occupied 78.7% of the North American market share in 2022. This is due to the high adoption of pets by the USA population. Over the past three decades, the number of Americans who keep pets has increased dramatically.
The number of Americans who own pets is steadily increasing, and pet insurance is also becoming more and more popular. Because of its growing popularity, pet care is now costing their owners more money overall, which is helping the market for wound care to expand.
China dominated the East Asia market with over 45.0% value share and is expected to grow significantly at a CAGR of close to 11.2% over the forecast duration.
As China's pet ownership and healthcare awareness continue to rise, the demand for specialized veterinary wound care products and services increases. Other than this, urbanization in China has led to changes in lifestyle and family structures, with more people living in apartments or smaller homes. This shift encourages pet owners to prioritize the health and well-being of their companion animals, including seeking proper wound care when necessary.
In 2022, Germany held a significant share of the Europe market and contributed around US$ 74.9 Million.
The German population is predicted to adopt more dogs and cats, which will boost the need for their vaccinations and the need for healthcare to keep them from contracting zoonotic diseases. These factors are anticipated to drive the segment's growth over the course of the forecast year. For instance, the European Pet Food Industry report estimated that in 2021 Germany would have 10,300,000 dogs and 16,700,000 cats. According to estimates, pet adoption will increase healthcare costs and spur industry expansion.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
By product, surgical wound care products held 61.4% market share in the world in 2022. This segment is expected to expand at a CAGR of around 8.5% in the forecasted period.
In veterinary practice, animal wounds are frequently witnessed and are almost often traumatic or the result of surgery. The goal of clinical care is to quickly restore health while removing the possibility of delayed wound healing. The use of surgical wound care products is being accelerated by this issue.
The market value of companion animals is representing a sizable market share of around 64.2% in 2022. This is due to the fact that the spending on veterinary care by the owners is skyrocketing in developed countries.
According to the American Veterinarian Medical Association, a single household spent US$ 326 on veterinarian services and medication on average in 2020, which was 33% of all expenditures on domestic pets in the USA.
The veterinary hospitals & clinics have a considerable presence in the veterinary wound care market, accounting for 74.2% value share in 2022, and exhibiting a high CAGR of 8.5% over the forecast period.
In order to handle the majority of health issues, animal hospitals and veterinary clinics provide specialized care, including surgery, therapy, and nursing. Additionally, the frequency of routine veterinarian visits is increasing, which aids in the early detection of disorders, enabling prompt treatment and promoting the long, happy, and healthy lives of pets. This is the reason why the veterinary hospitals & clinics segment is the dominant one.
It is crucial to create creative and efficient wound care products that are catered to the unique requirements of various animal species. Continuous product development and improvements help maintain a competitive edge and meet evolving customer demands. Forming strategic partnerships and collaborations with veterinary hospitals, research institutions, and key opinion leaders can help validate products, expand market reach, and drive product adoption.
Following are the instances of the key developments for the key players in this market:
Similarly, recent developments related to the companies manufacturing the veterinary wound care products have been tracked by the team at Future Market Insights, which are available in the full report.
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2012 to 2022 |
Market Analysis | US$ Million for Value |
Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East and Africa (MEA) |
Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Spain, BENELUX, Russia, China, Japan, South Korea, India, Indonesia, Thailand, Malaysia, Australia, New Zealand, GCC Countries, Türkiye, Northern Africa and South Africa. |
Key Market Segments Covered | Product, Animal Type, End User, and Region |
Key Companies Profiled | Elanco; Virbac; Medtronic; B Braun; Jorgen Kruuse; Dechra Pharmaceuticals; Neogen Corporation; Ethicon; Sonoma Pharma; Jazz Medical; KAKEN PHARMACEUTICAL CO., LTD.; KOB GmbH |
Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Pricing | Available upon Request |
The market expanded at a CAGR of 5.6% from 2018 to 2022.
Elanco, Virbac, and Medtronic are the key market players.
Demand for specialized veterinary wound care products and services.
This market is valued at US$ 1.2 billion in 2023.
This market is estimated to reach US$ 2.8 billion by 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value-Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / features
4.3. Recent Product Approvals and Launches
4.4. Regulatory Scenario, By Country
4.5. Reimbursement Scenario, By Country
4.6. PESTLE Analysis
4.7. Porter’s Analysis
4.8. Value Chain Analysis
4.9. Unmet Needs and Opportunities
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Veterinary Healthcare Outlook
5.1.3. Global Wound Care Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Historical Growth of the Top Companies
5.2.2. New/Improved Product Launches
5.2.3. Rise in Adoption of Pets
5.2.4. Technological Advancements
5.2.5. Regulatory Environment
5.2.6. Strategic Collaborations & Partnerships
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022
6.2. Current and Future Market Size (US$ Million) Analysis and Forecast, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
6.3. Revenue Opportunity Scenario
7. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Million) Analysis By Product, 2012 to 2022
7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2023 to 2033
7.3.1. Surgical Wound Care Products
7.3.2. Advanced Wound Care Products
7.3.3. Traditional Wound Care Products
7.3.4. Therapy Devices
7.4. Market Attractiveness Analysis By Product
8. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Animal Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis, By Animal Type, 2012 to 2022
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Animal Type, 2023 to 2033
8.3.1. Companion Animal
8.3.2. Livestock Animal
8.4. Market Attractiveness Analysis By Animal Type
9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis, By End User, 2012 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
9.3.1. Veterinary Hospitals & Clinics
9.3.2. Homecare
9.3.3. Research Institutes
9.4. Market Attractiveness Analysis By End User
10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis By Region, 2012 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
11.3.1. By Country
11.3.1.1. USA
11.3.1.2. Canada
11.3.2. By Product
11.3.3. By Animal Type
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Product
11.4.3. By Animal Type
11.4.4. By End User
11.5. Market Trends
11.6. Key Market Participants - Intensity Mapping
11.7. Drivers and Restraints - Impact Analysis
11.8. Country Level Analysis & Forecast
11.8.1. USA Market Analysis
11.8.1.1. Introduction
11.8.1.2. Market Analysis and Forecast by Market Taxonomy
11.8.1.2.1. By Product
11.8.1.2.2. By Animal Type
11.8.1.2.3. By End User
11.8.2. Canada Market Analysis
11.8.2.1. Introduction
11.8.2.2. Market Analysis and Forecast by Market Taxonomy
11.8.2.2.1. By Product
11.8.2.2.2. By Animal Type
11.8.2.2.3. By End User
12. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
12.3.1. By Country
12.3.1.1. Mexico
12.3.1.2. Brazil
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. By Product
12.3.3. By Animal Type
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Animal Type
12.4.4. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
12.8.1. Mexico Market Analysis
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Product
12.8.1.2.2. By Animal Type
12.8.1.2.3. By End User
12.8.2. Brazil Market Analysis
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Product
12.8.2.2.2. By Animal Type
12.8.2.2.3. By End User
12.8.3. Argentina Market Analysis
12.8.3.1. Introduction
12.8.3.2. Market Analysis and Forecast by Market Taxonomy
12.8.3.2.1. By Product
12.8.3.2.2. By Animal Type
12.8.3.2.3. By End User
13. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. UK
13.3.1.2. Germany
13.3.1.3. Italy
13.3.1.4. France
13.3.1.5. Spain
13.3.1.6. Russia
13.3.1.7. BENELUX
13.3.1.8. Rest of Europe
13.3.2. By Product
13.3.3. By Animal Type
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Animal Type
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
13.8.1. UK Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Animal Type
13.8.1.2.3. By End User
13.8.2. Germany Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Animal Type
13.8.2.2.3. By End User
13.8.3. Italy Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. B By Product
13.8.3.2.2. By Animal Type
13.8.3.2.3. By End User
13.8.4. France Market Analysis
13.8.4.1. Introduction
13.8.4.2. Market Analysis and Forecast by Market Taxonomy
13.8.4.2.1. By Product
13.8.4.2.2. By Animal Type
13.8.4.2.3. By End User
13.8.5. Spain Market Analysis
13.8.5.1. Introduction
13.8.5.2. Market Analysis and Forecast by Market Taxonomy
13.8.5.2.1. By Product
13.8.5.2.2. By Animal Type
13.8.5.2.3. By End User
13.8.6. Russia Market Analysis
13.8.6.1. Introduction
13.8.6.2. Market Analysis and Forecast by Market Taxonomy
13.8.6.2.1. By Product
13.8.6.2.2. By Animal Type
13.8.6.2.3. By End User
13.8.7. BENELUX Market Analysis
13.8.7.1. Introduction
13.8.7.2. Market Analysis and Forecast by Market Taxonomy
13.8.7.2.1. By Product
13.8.7.2.2. By Animal Type
13.8.7.2.3. By End User
14. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Product
14.3.3. By Animal Type
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Animal Type
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. China Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Animal Type
14.8.1.2.3. By End User
14.8.2. Japan Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Animal Type
14.8.2.2.3. By End User
14.8.3. South Korea Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Animal Type
14.8.3.2.3. By End User
15. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Indonesia
15.3.1.3. Malaysia
15.3.1.4. Thailand
15.3.1.5. Rest of South Asia
15.3.2. By Product
15.3.3. By Animal Type
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Animal Type
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. India Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Animal Type
15.8.1.2.3. By End User
15.8.2. Indonesia Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Animal Type
15.8.2.2.3. By End User
15.8.3. Malaysia Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Animal Type
15.8.3.2.3. By End User
15.8.4. Thailand Market Analysis
15.8.4.1. Introduction
15.8.4.2. Market Analysis and Forecast by Market Taxonomy
15.8.4.2.1. By Product
15.8.4.2.2. By Animal Type
15.8.4.2.3. By End User
16. Oceania Market 2012 to 2022 and Forecast 2023-2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Product
16.3.3. By Animal Type
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Animal Type
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Australia Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Animal Type
16.8.1.2.3. By End User
16.8.2. New Zealand Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Animal Type
16.8.2.2.3. By End User
17. Middle East and Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2012 to 2022
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast, By Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Türkiye
17.3.1.3. South Africa
17.3.1.4. Northern Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Product
17.3.3. By Animal Type
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Animal Type
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. GCC Countries Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Animal Type
17.8.1.2.3. By End User
17.8.2. Türkiye Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Animal Type
17.8.2.2.3. By End User
17.8.3. South Africa Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Animal Type
17.8.3.2.3. By End User
17.8.4. Northern Africa Market Analysis
17.8.4.1. Introduction
17.8.4.2. Market Analysis and Forecast by Market Taxonomy
17.8.4.2.1. By Product
17.8.4.2.2. By Animal Type
17.8.4.2.3. By End User
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Share Analysis of Top Players
18.3. Market Presence Analysis
18.3.1. By Regional Footprint of Players
18.3.2. By Channel Footprint of Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Branding and Promotional Strategies by Key Players
19.3. Key Development Analysis
19.4. Competition Deep Dive
19.4.1. Elanco
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Key Financials
19.4.1.4. Sales Footprint
19.4.1.5. SWOT Analysis
19.4.1.6. Strategy Overview
19.4.1.6.1. Marketing Strategy
19.4.1.6.2. Product Strategy
19.4.1.6.3. Channel Strategy
19.4.2. Virbac
19.4.2.1. Overview
19.4.2.2. Product Portfolio
19.4.2.3. Key Financials
19.4.2.4. Sales Footprint
19.4.2.5. SWOT Analysis
19.4.2.6. Strategy Overview
19.4.2.6.1. Marketing Strategy
19.4.2.6.2. Product Strategy
19.4.2.6.3. Channel Strategy
19.4.3. Medtronic
19.4.3.1. Overview
19.4.3.2. Product Portfolio
19.4.3.3. Key Financials
19.4.3.4. Sales Footprint
19.4.3.5. SWOT Analysis
19.4.3.6. Strategy Overview
19.4.3.6.1. Marketing Strategy
19.4.3.6.2. Product Strategy
19.4.3.6.3. Channel Strategy
19.4.4. B Braun
19.4.4.1. Overview
19.4.4.2. Product Portfolio
19.4.4.3. Key Financials
19.4.4.4. Sales Footprint
19.4.4.5. SWOT Analysis
19.4.4.6. Strategy Overview
19.4.4.6.1. Marketing Strategy
19.4.4.6.2. Product Strategy
19.4.4.6.3. Channel Strategy
19.4.5. Jorgen Kruuse
19.4.5.1. Overview
19.4.5.2. Product Portfolio
19.4.5.3. Key Financials
19.4.5.4. Sales Footprint
19.4.5.5. SWOT Analysis
19.4.5.6. Strategy Overview
19.4.5.6.1. Marketing Strategy
19.4.5.6.2. Product Strategy
19.4.5.6.3. Channel Strategy
19.4.6. Dechra Pharmaceuticals
19.4.6.1. Overview
19.4.6.2. Product Portfolio
19.4.6.3. Key Financials
19.4.6.4. Sales Footprint
19.4.6.5. SWOT Analysis
19.4.6.6. Strategy Overview
19.4.6.6.1. Marketing Strategy
19.4.6.6.2. Product Strategy
19.4.6.6.3. Channel Strategy
19.4.7. Neogen Corporation
19.4.7.1. Overview
19.4.7.2. Product Portfolio
19.4.7.3. Key Financials
19.4.7.4. Sales Footprint
19.4.7.5. SWOT Analysis
19.4.7.6. Strategy Overview
19.4.7.6.1. Marketing Strategy
19.4.7.6.2. Product Strategy
19.4.7.6.3. Channel Strategy
19.4.8. Ethicon
19.4.8.1. Overview
19.4.8.2. Product Portfolio
19.4.8.3. Key Financials
19.4.8.4. Sales Footprint
19.4.8.5. SWOT Analysis
19.4.8.6. Strategy Overview
19.4.8.6.1. Marketing Strategy
19.4.8.6.2. Product Strategy
19.4.8.6.3. Channel Strategy
19.4.9. Sonoma Pharma
19.4.9.1. Overview
19.4.9.2. Product Portfolio
19.4.9.3. Key Financials
19.4.9.4. Sales Footprint
19.4.9.5. SWOT Analysis
19.4.9.6. Strategy Overview
19.4.9.6.1. Marketing Strategy
19.4.9.6.2. Product Strategy
19.4.9.6.3. Channel Strategy
19.4.10. Jazz Medical
19.4.10.1. Overview
19.4.10.2. Product Portfolio
19.4.10.3. Key Financials
19.4.10.4. Sales Footprint
19.4.10.5. SWOT Analysis
19.4.10.6. Strategy Overview
19.4.10.6.1. Marketing Strategy
19.4.10.6.2. Product Strategy
19.4.10.6.3. Channel Strategy
19.4.11. KAKEN PHARMACEUTICAL CO., LTD.
19.4.11.1. Overview
19.4.11.2. Product Portfolio
19.4.11.3. Key Financials
19.4.11.4. Sales Footprint
19.4.11.5. SWOT Analysis
19.4.11.6. Strategy Overview
19.4.11.6.1. Marketing Strategy
19.4.11.6.2. Product Strategy
19.4.11.6.3. Channel Strategy
19.4.12. KOB GmbH
19.4.12.1. Overview
19.4.12.2. Product Portfolio
19.4.12.3. Key Financials
19.4.12.4. Sales Footprint
19.4.12.5. SWOT Analysis
19.4.12.6. Strategy Overview
19.4.12.6.1. Marketing Strategy
19.4.12.6.2. Product Strategy
19.4.12.6.3. Channel Strategy
20. Assumptions and Acronyms User
21. Research Methodology
Explore Healthcare Insights
View Reports